Hundreds of Years Combined Innovation Experience
Our Leaders
Our ability to launch new therapeutic solutions is supported by extensive leadership experience. Various team members have developed and/or launched successful products, including several that were first-in-class and/or reached iconic status. Our strategy leverages this relevant experience to meaningfully benefit underserved patients through the in-licensing, acquisition, development, and commercialization of innovative therapeutics.
Andrew Sklawer
Co-Founder, President & Chief Executive Officer


Andrew Sklawer
Co-Founder, President & Chief Executive Officer
Bert Marchio
Chief Financial Officer


Bert Marchio
Chief Financial Officer
David McAvoy
General Counsel & Chief Compliance Officer


David McAvoy
General Counsel & Chief Compliance Officer
Aron Aizenstat
Vice President, Corporate Development & Operations


Aron Aizenstat
Vice President, Corporate Development & Operations
Sue Fattor
Head of Human Resources


Sue Fattor
Head of Human Resources
Aaron Fox-Collis, CPA
Vice President, Finance & Chief Accounting Officer


Aaron Fox-Collis, CPA
Vice President, Finance & Chief Accounting Officer
James S. McElvain
Interim Head of CMC Development

